Therapeutics for COVID-19: from computation to practices—where we are, where we are heading to

[1] Wu F(2020)A new coronavirus associated with human respiratory disease in China Nature 579 265-269

[2] Zhao S(2020)A pneumonia outbreak associated with a new coronavirus of probable bat origin Nature 579 270-273

[3] Yu B(2018)Epidemiology and clinical characteristics of human coronaviruses OC43, 229E, NL63, and HKU1: a study of hospitalized children with acute respiratory tract infection in Guangzhou, China Eur J Clin Microbiol Infect Dis 37 363-369

[4] Zhou P(2020)A novel coronavirus from patients with pneumonia in China, 2019 N Engl J Med 382 727-733

[5] Yang X-L(2020)Potential of large “first generation” human-to-human transmission of 2019-nCoV J Med Virol 92 448-454

[6] Wang X-G(2020)The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade Antivir Res 176 104742-331

[7] Zeng ZQ(2018)Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2 PLoS Pathog 14 e1007236-557

[8] Chen DH(2020)Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases ACS Cent Sci 6 315-271

[9] Tan WP(2019)Human coronavirus: host–pathogen interaction Annu Rev Microbiol 73 529-1799

[10] Zhu N(2020)In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Clin Infect Dis 55 105960-412

[1] Wu F(2020)A new coronavirus associated with human respiratory disease in China Nature 579 265-269

[2] Zhao S(2020)A pneumonia outbreak associated with a new coronavirus of probable bat origin Nature 579 270-273

[3] Yu B(2018)Epidemiology and clinical characteristics of human coronaviruses OC43, 229E, NL63, and HKU1: a study of hospitalized children with acute respiratory tract infection in Guangzhou, China Eur J Clin Microbiol Infect Dis 37 363-369

[4] Zhou P(2020)A novel coronavirus from patients with pneumonia in China, 2019 N Engl J Med 382 727-733

[5] Yang X-L(2020)Potential of large “first generation” human-to-human transmission of 2019-nCoV J Med Virol 92 448-454

[6] Wang X-G(2020)The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade Antivir Res 176 104742-331

[7] Zeng ZQ(2018)Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2 PLoS Pathog 14 e1007236-557

[8] Chen DH(2020)Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases ACS Cent Sci 6 315-271

[9] Tan WP(2019)Human coronavirus: host–pathogen interaction Annu Rev Microbiol 73 529-1799

[10] Zhu N(2020)In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Clin Infect Dis 55 105960-412